Inimmune Corp
Missoula, MT
- UEI
- EF8AMXMGG8W5
- CAGE
- 7U1Q8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1121 E Broadway St #121, Missoula, MT 59802, USA
- Website
- inimmune.com
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of SAS a synthetic AS01-like adjuvant system for influenza vaccines | National Institute of Allergy and Infectious Diseases | $5,907,864 | |
| EO 14042 | National Institute of Allergy and Infectious Diseases | $1,836,453 | |
| Adjuvant discovery for vaccines and for autoimmune and allergic diseases | National Institute of Allergy and Infectious Diseases | $598,808 | |
| Production of synthetic adjuvant system (SAS): a synergistic combination of synthetic adjuvant components | National Institute of Allergy and Infectious Diseases | $1,992,471 | |
| "discovery of new small molecule TLR4 agonists for the treatment of allergic rhinitis" | National Institute of Allergy and Infectious Diseases | $631,425 |
About Inimmune Corp
Inimmune Corp is a promising new biotechnology company founded by pharmaceutical industry veterans, focused on developing the next generation of vaccines and immunotherapeutics. The group has extensive expertise in synthetic and process chemistry, drug formulation, and pharmaceutical manufacturing.
Inimmune has received several prime federal contract awards from the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). These include contracts for developing a synthetic AS01-like adjuvant system for influenza vaccines, a new Toll-like receptor 4 agonist treatment for allergic rhinitis under the SBIR program, adjuvant discovery for vaccines and autoimmune/allergic diseases under SBIR Phase I, and development of a Synthetic Adjuvant System under SBIR Phase II. The awards are primarily firm fixed price contracts and many have a total small business set-aside designation. Inimmune has also received several sub-contract awards from institutions like Oregon Health & Science University, Duke University, and the University of California San Diego for projects involving vaccine adjuvants, immunotherapeutics, and novel antibiotics.
Through federal grant sub-awards, Inimmune has supported research at the University of Montana on immunization against filamentous bacteriophages to prevent bacterial infection. The company has collaborated with Oregon Health & Science University on projects focused on developing novel STING pathway agonists as vaccine adjuvants and targeting IRFs for immune adjuvant enhancement of vaccine immunogenicity.
SBA capabilities narrative
Cell-based potency assays
Octet Red-based affinity measurements
Synthesis
drug formulation
Quick answers
What is Inimmune Corp's UEI?
Inimmune Corp's Unique Entity ID (UEI) in SAM.gov is EF8AMXMGG8W5.
What is Inimmune Corp's CAGE code?
Inimmune Corp's CAGE code is 7U1Q8.
What is Inimmune Corp's primary NAICS code?
Inimmune Corp's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Inimmune Corp located?
Inimmune Corp's physical address in SAM.gov is 1121 E Broadway St #121, Missoula, MT 59802, USA.
Is Inimmune Corp registered in SAM.gov?
Yes. Inimmune Corp's SAM.gov registration is active through December 8, 2026.
What is Inimmune Corp's most recent federal award?
Inimmune Corp's most recent federal contract award is Development of SAS a synthetic AS01-like adjuvant system for influenza vaccines (75N93023C00042), from National Institute of Allergy and Infectious Diseases, on September 30, 2023.
On GovTribe
See Inimmune Corp's full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors